Title |
Acute exacerbations of COPD: risk factors for failure and relapse
|
---|---|
Published in |
International Journal of Chronic Obstructive Pulmonary Disease, September 2017
|
DOI | 10.2147/copd.s145253 |
Pubmed ID | |
Authors |
Marco Mantero, Paola Rogliani, Marta Di Pasquale, Eva Polverino, Ernesto Crisafulli, Monica Guerrero, Andrea Gramegna, Mario Cazzola, Francesco Blasi |
Abstract |
Acute exacerbations are a leading cause of worsening COPD in terms of lung function decline, quality of life, and survival. They also have a relevant economic burden on the health care system. Determining the risk factors for acute exacerbation and early relapse could be a crucial element for a better management of COPD patients. This review analyzes the current knowledge and underlines the main risk factors for recurrent acute exacerbations. Comprehensive evaluation of COPD patients during stable phase and exacerbation could contribute to prevent treatment failure and relapses. |
X Demographics
Geographical breakdown
Country | Count | As % |
---|---|---|
Canada | 1 | 25% |
Mexico | 1 | 25% |
Unknown | 2 | 50% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Practitioners (doctors, other healthcare professionals) | 2 | 50% |
Scientists | 1 | 25% |
Members of the public | 1 | 25% |
Mendeley readers
Geographical breakdown
Country | Count | As % |
---|---|---|
Unknown | 120 | 100% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Student > Master | 19 | 16% |
Other | 10 | 8% |
Student > Ph. D. Student | 10 | 8% |
Researcher | 9 | 8% |
Student > Bachelor | 9 | 8% |
Other | 21 | 18% |
Unknown | 42 | 35% |
Readers by discipline | Count | As % |
---|---|---|
Medicine and Dentistry | 32 | 27% |
Biochemistry, Genetics and Molecular Biology | 7 | 6% |
Nursing and Health Professions | 6 | 5% |
Pharmacology, Toxicology and Pharmaceutical Science | 5 | 4% |
Immunology and Microbiology | 3 | 3% |
Other | 17 | 14% |
Unknown | 50 | 42% |